Acute effects of Helicobacter pylori extracts on gastric mucosal blood flow in the mouse

World Journal of Gastroenterology

Volumn 15, Issue 2, 2009, Pages 219-225

  Henriksnäs, Johanna ^a   Atuma, Christer ^a   Phillipson, Mia ^a   Sandler, Stellan ^a   Engstrand, Lars ^b   Holm, Lena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Gastric mucosal blood flow; Helicobacter pylori; In vivo; Laser Doppler flowmetry; Mice

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; LIDOCAINE; N(G),N(G) DIMETHYLARGININE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOWMETRY; C57BL 6 MOUSE; CONTROLLED STUDY; HELICOBACTER PYLORI; LASER DOPPLER FLOWMETRY; MALE; MOUSE; NONHUMAN; STOMACH INNERVATION; STOMACH MUCOSA BLOOD FLOW; WILD TYPE;

EID: 59249085252     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.219     Document Type: Article

References (29)

1. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353
2. Atuma C, Engstrand L, Holm L. Helicobacter pylori extracts reduce gastric mucosal blood flow by a nitric oxideindependent but mast cell- and platelet-activating factor receptor-dependent pathway in rats. Scand J Gastroenterol 1999; 34: 1183-1189
3. Whittle BJ, Morishita T, Ohya Y, Leung FW, Guth PH. Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa. Am J Physiol 1986; 251: G772-G778
4. Kubes P, Ibbotson G, Russell J, Wallace JL, Granger DN. Role of platelet-activating factor in ischemia/reperfusioninduced leukocyte adherence. Am J Physiol 1990; 259: G300-G305
5. Bonavida B, Mencia-Huerta JM. Platelet-activating factor and the cytokine network in inflammatory processes. Clin Rev Allergy 1994; 12: 381-395
6. Castagliuolo I, LaMont JT, Letourneau R, Kelly C, O'Keane JC, Jaffer A, Theoharides TC, Pothoulakis C. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 1994; 107: 657-665
7. Holzer P, Livingston EH, Guth PH. Neural, metabolic, physical, and endothelial factors in the regulation of the gastric circulation. In: Johnson LR, eds. Physiology of the gastrointestinal tract. 3rd ed. New York: Raven Press, 1994: 1311-1329
8. Kawano S, Tsuji S. Role of mucosal blood flow: a conceptional review in gastric mucosal injury and protection. J Gastroenterol Hepatol 2000; 15 Suppl: D1-D6
9. Synnerstad I, Johansson M, Nylander O, Holm L. Intraluminal acid and gastric mucosal integrity: the importance of blood-borne bicarbonate. Am J Physiol Gastrointest Liver Physiol 2001; 280: G121-G129
10. Phillipson M, Henriksnäs J, Holstad M, Sandler S, Holm L. Inducible nitric oxide synthase is involved in acid-induced gastric hyperemia in rats and mice. Am J Physiol Gastrointest Liver Physiol 2003; 285: G154-G162
11. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999; 116: 1319-1329
12. Fändriks L, von Bothmer C, Johansson B, Holm M, Bolin I, Pettersson A. Water extract of Helicobacter pylori inhibits duodenal mucosal alkaline secretion in anesthetized rats. Gastroenterology 1997; 113: 1570-1575
13. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81: 641-650
14. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, Covacci A. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94-98
15. Atuma C, Engstrand L, Holm L. Extracts of Helicobacter pylori reduce gastric mucosal blood flow through a VacA- and CagA-independent pathway in rats. Scand J Gastroenterol 1998; 33: 1256-1261
16. Henriksnäs J, Phillipson M, Petersson J, Engstrand L, Holm L. An in vivo model for gastric physiological and pathophysiological studies in the mouse. Acta Physiol Scand 2005; 184: 151-159
17. Holm-Rutili L, Berglindh T. Pentagastrin and gastric mucosal blood flow. Am J Physiol 1986; 250: G575-G580
18. Kvietys PR, Shepherd AP, Granger DN. Laser-Doppler, H2 clearance, and microsphere estimates of mucosal blood flow. Am J Physiol 1985; 249: G221-G227
19. Ahn H, Lindhagen J, Nilsson GE, Salerud EG, Jodal M, Lundgren O. Evaluation of laser Doppler flowmetry in the assessment of intestinal blood flow in cat. Gastroenterology 1985; 88: 951-957
20. Johansson K, Ahn H, Lindhagen J, Lundgren O. Tissue penetration and measuring depth of laser Doppler flowmetry in the gastrointestinal application. Scand J Gastroenterol 1987; 22: 1081-1088
21. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989; 97: 575-585
22. Holm M, Powell T, Casselbrant A, Johansson B, Fandriks L. Dynamic involvement of the inducible type of nitric oxide synthase in acid-induced duodenal mucosal alkaline secretion in the rat. Dig Dis Sci 2001; 46: 1765-1771
23. Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999; 43: 542-548
24. von Bothmer C, Edebo A, Lonroth H, Olbe L, Pettersson A, Fandriks L. Helicobacter pylori infection inhibits antral mucosal nitric oxide production in humans. Scand J Gastroenterol 2002; 37: 404-408
25. Boer R, Ulrich WR, Klein T, Mirau B, Haas S, Baur I. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol 2000; 58: 1026-1034
26. Elizalde JI, Mendez A, Gomez J, del Rivero M, Gironella M, Closa D, Quintero E, Pique JM. Gastric mucosal blood flow changes in Helicobacter pylori infection and NSAIDinduced gastric injury. Helicobacter 2003; 8: 124-131
27. Shiotani A, Yanaoka K, Iguchi M, Saika A, Itoh H, Nishioka S. Helicobacter pylori infection reduces intraluminal nitric oxide in humans. J Gastroenterol 1999; 34: 668-674
28. Gobert AP, McGee DJ, Akhtar M, Mendz GL, Newton JC, Cheng Y, Mobley HL, Wilson KT. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 2001; 98: 13844-13849
29. Henriksnäs J, Phillipson M, Storm M, Engstrand L, Soleimani M, Holm L. Impaired mucus-bicarbonate barrier in Helicobacter pylori-infected mice. Am J Physiol Gastrointest Liver Physiol 2006; 291: G396-G403